Dr. Denise Yardley
Claim this profileSCRI Oncology Partners
Expert in Breast Cancer
Studies Breast cancer
12 reported clinical trials
25 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
HER2 positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Denise Yardley is currently running
Abemaciclib + Elacestrant
for Brain Metastasis from Breast Cancer
This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Recruiting1 award Phase 1 & 212 criteria
Sacituzumab Govitecan + Trastuzumab
for Breast Cancer
This research study is being done to evaluate the safety and effectiveness of sacituzumab govitecan with trastuzumab (Herceptin, Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer. The names of the study drugs used in this research study are: * Sacituzumab govitecan (a type of antibody-drug conjugate) * Trastuzumab (Herceptin) (a type of monoclonal antibody) * Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) (a type of recombinant monoclonal antibody) * Trastuzumab biosimilar drug
Recruiting1 award Phase 218 criteria
More about Denise Yardley
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Denise Yardley has experience with
- Trastuzumab
- Paclitaxel
- Trastuzumab SC
- Trastuzumab-emtansine
- Abemaciclib
- Elacestrant
Breakdown of trials Denise Yardley has run
Breast Cancer
Breast cancer
Central Nervous System Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Denise Yardley specialize in?
Denise Yardley focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Denise Yardley currently recruiting for clinical trials?
Yes, Denise Yardley is currently recruiting for 8 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Denise Yardley has studied deeply?
Yes, Denise Yardley has studied treatments such as Trastuzumab, Paclitaxel, Trastuzumab SC.
What is the best way to schedule an appointment with Denise Yardley?
Apply for one of the trials that Denise Yardley is conducting.
What is the office address of Denise Yardley?
The office of Denise Yardley is located at: SCRI Oncology Partners, Nashville, Tennessee 37203 United States. This is the address for their practice at the SCRI Oncology Partners.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.